Literature DB >> 26912653

Explaining the Serological Characteristics of Streptococcus suis Serotypes 1 and 1/2 from Their Capsular Polysaccharide Structure and Biosynthesis.

Marie-Rose Van Calsteren1, Guillaume Goyette-Desjardins2, Fleur Gagnon3, Masatoshi Okura4, Daisuke Takamatsu5, René Roy6, Marcelo Gottschalk2, Mariela Segura7.   

Abstract

The capsular polysaccharide (CPS) is a major virulence factor in many encapsulated pathogens, as it is the case for Streptococcus suis, an important swine pathogen and emerging zoonotic agent. Moreover, the CPS is the antigen at the origin of S. suis classification into serotypes. Hence, analyses of the CPS structure are an essential step to dissect its role in virulence and the serological relations between important serotypes. Here, the CPSs of serotypes 1 and 1/2 were purified and characterized for the first time. Chemical and spectroscopic data gave the following repeating unit sequences: [6)[Neu5Ac(α2-6)GalNAc(β1-4)GlcNAc(β1-3)]Gal(β1-3)Gal(β1-4)Glc(β1-]n (serotype 1) and [4)[Neu5Ac(α2-6)GalNAc(β1-4)GlcNAc(β1-3)]Gal(β1-4)[Gal(α1-3)]Rha(β1-4)Glc(β1-]n (serotype 1/2). The Sambucus nigra lectin, which recognizes the Neu5Ac(α2-6)Gal/GalNAc sequence, showed binding to both CPSs. Compared with previously characterized serotype 14 and 2 CPSs, N-acetylgalactosamine replaces galactose as the sugar bearing the sialic acid residue in the side chain. Serological analyses of the cross-reaction of serotype 1/2 with serotypes 1 and 2 and that between serotypes 1 and 14 suggested that the side chain, and more particularly the terminal sialic acid, constitutes one important epitope for serotypes 1/2 and 2. The side chain is also an important serological determinant for serotype 1, yet sialic acid seems to play a limited role. In contrast, the side chain does not seem to be part of a major epitope for serotype 14. These results contribute to the understanding of the relationship between S. suis serotypes and provide the basis for improving diagnostic tools.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Streptococcus; carbohydrate structure; chemical biology; immunochemistry; polysaccharide; sialic acid

Mesh:

Substances:

Year:  2016        PMID: 26912653      PMCID: PMC4861414          DOI: 10.1074/jbc.M115.700716

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Structural analysis of glycans by NMR chemical shift prediction.

Authors:  Magnus Lundborg; Göran Widmalm
Journal:  Anal Chem       Date:  2011-01-31       Impact factor: 6.986

2.  Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII.

Authors:  Francesco Berti; Edmondo Campisi; Chiara Toniolo; Laura Morelli; Stefano Crotti; Roberto Rosini; Maria Rosaria Romano; Vittoria Pinto; Barbara Brogioni; Giulia Torricelli; Robert Janulczyk; Guido Grandi; Immaculada Margarit
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

3.  Role of the capsular polysaccharide as a virulence factor for Streptococcus suis serotype 14.

Authors:  David Roy; Jean-Philippe Auger; Mariela Segura; Nahuel Fittipaldi; Daisuke Takamatsu; Masatoshi Okura; Marcelo Gottschalk
Journal:  Can J Vet Res       Date:  2015-04       Impact factor: 1.310

4.  Description of six new capsular types (29-34) of Streptococcus suis.

Authors:  R Higgins; M Gottschalk; M Boudreau; A Lebrun; J Henrichsen
Journal:  J Vet Diagn Invest       Date:  1995-07       Impact factor: 1.279

5.  Reporter resonances in the NMR spectra of oligosaccharides containing sialic acid linked to galactopyranose rings.

Authors:  D Machytka; R A Klein; H Egge
Journal:  Carbohydr Res       Date:  1994-02-17       Impact factor: 2.104

6.  Streptococcus suis serotype 2 mutants deficient in capsular expression.

Authors:  N Charland; J Harel; M Kobisch; S Lacasse; M Gottschalk
Journal:  Microbiology (Reading)       Date:  1998-02       Impact factor: 2.777

7.  Structure determination of Streptococcus suis serotype 14 capsular polysaccharide.

Authors:  Marie-Rose Van Calsteren; Fleur Gagnon; Cynthia Calzas; Guillaume Goyette-Desjardins; Masatoshi Okura; Daisuke Takamatsu; Marcelo Gottschalk; Mariela Segura
Journal:  Biochem Cell Biol       Date:  2012-12-03       Impact factor: 3.626

8.  1H, 13C and 15N chemical shift referencing in biomolecular NMR.

Authors:  D S Wishart; C G Bigam; J Yao; F Abildgaard; H J Dyson; E Oldfield; J L Markley; B D Sykes
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

9.  Capsular sialic acid of Streptococcus suis serotype 2 binds to swine influenza virus and enhances bacterial interactions with virus-infected tracheal epithelial cells.

Authors:  Yingchao Wang; Carl A Gagnon; Christian Savard; Nedzad Music; Mariela Srednik; Mariela Segura; Claude Lachance; Christian Bellehumeur; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2013-09-30       Impact factor: 3.441

10.  The type-specific polysaccharides of Streptococcus suis.

Authors:  S D Elliott; J Y Tai
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  13 in total

1.  Development of a mismatch amplification mutation assay to correctly serotype isolates of Streptococcus suis serotypes 1, 2, 1/2, and 14.

Authors:  Sonia Lacouture; Masatoshi Okura; Daisuke Takamatsu; Lorelei Corsaut; Marcelo Gottschalk
Journal:  J Vet Diagn Invest       Date:  2020-04-20       Impact factor: 1.279

2.  Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.

Authors:  Guillaume Goyette-Desjardins; Cynthia Calzas; Tze Chieh Shiao; Axel Neubauer; Jennifer Kempker; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

3.  A single amino acid polymorphism in the glycosyltransferase CpsK defines four Streptococcus suis serotypes.

Authors:  David Roy; Taryn B T Athey; Jean-Philippe Auger; Guillaume Goyette-Desjardins; Marie-Rose Van Calsteren; Daisuke Takamatsu; Masatoshi Okura; Sarah Teatero; Martín Alcorlo; Juan A Hermoso; Mariela Segura; Marcelo Gottschalk; Nahuel Fittipaldi
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

4.  Capsular Sialyltransferase Specificity Mediates Different Phenotypes in Streptococcus suis and Group B Streptococcus.

Authors:  David Roy; Daisuke Takamatsu; Masatoshi Okura; Guillaume Goyette-Desjardins; Marie-Rose Van Calsteren; Audrey Dumesnil; Marcelo Gottschalk; Mariela Segura
Journal:  Front Microbiol       Date:  2018-04-03       Impact factor: 5.640

5.  Interactions of Streptococcus suis serotype 9 with host cells and role of the capsular polysaccharide: Comparison with serotypes 2 and 14.

Authors:  Jean-Philippe Auger; Servane Payen; David Roy; Audrey Dumesnil; Mariela Segura; Marcelo Gottschalk
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

6.  Capsular polysaccharide switching in Streptococcus suis modulates host cell interactions and virulence.

Authors:  Masatoshi Okura; Jean-Philippe Auger; Tomoyuki Shibahara; Guillaume Goyette-Desjardins; Marie-Rose Van Calsteren; Fumito Maruyama; Mikihiko Kawai; Makoto Osaki; Mariela Segura; Marcelo Gottschalk; Daisuke Takamatsu
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

7.  Determining Streptococcus suis serotype from short-read whole-genome sequencing data.

Authors:  Taryn B T Athey; Sarah Teatero; Sonia Lacouture; Daisuke Takamatsu; Marcelo Gottschalk; Nahuel Fittipaldi
Journal:  BMC Microbiol       Date:  2016-07-22       Impact factor: 3.605

8.  Role of the Streptococcus suis serotype 2 capsular polysaccharide in the interactions with dendritic cells is strain-dependent but remains critical for virulence.

Authors:  Jean-Philippe Auger; Dominic Dolbec; David Roy; Mariela Segura; Marcelo Gottschalk
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

9.  Characterization and Protective Activity of Monoclonal Antibodies Directed against Streptococcus suis Serotype 2 Capsular Polysaccharide Obtained Using a Glycoconjugate.

Authors:  Guillaume Goyette-Desjardins; Sonia Lacouture; Jean-Philippe Auger; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  Pathogens       Date:  2019-09-07

10.  Comparative Study of Immunogenic Properties of Purified Capsular Polysaccharides from Streptococcus suis Serotypes 3, 7, 8, and 9: the Serotype 3 Polysaccharide Induces an Opsonizing IgG Response.

Authors:  Guillaume Goyette-Desjardins; Jean-Philippe Auger; Dominic Dolbec; Evgeny Vinogradov; Masatoshi Okura; Daisuke Takamatsu; Marie-Rose Van Calsteren; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.